Professor of Medicine
Columbia University Irving Medical Center
Ran Reshef, MD MSc is a Professor of Medicine at Columbia University Irving Medical Center in New York. He serves as the Director of the Cellular Immunotherapy Program at Columbia. He is a member of the Blood and Marrow Transplantation Program and specializes in the treatment of lymphoma, leukemia, myeloma and other hematologic malignancies. He oversees the management of patients receiving commercial and experimental CAR-T cells and other forms of cancer immunotherapy. He directs a research lab in the Columbia Center for Translational Immunology, and he is a member of the NCI-designated Herbert Irving Comprehensive Cancer Center.
Dr. Reshef’s research revolves around development of immunotherapy approaches for the treatment of cancer and his lab studies novel ways to improve the efficacy and the safety of immunotherapies. Specific areas of research interest include CAR T cells therapies, graft-versus-host disease and development of single-cell techniques to analyze biospecimens for target and biomarker discovery.
